Jan 11th, 2021
China's Gracell Biotechnologies Lists on Nasdaq
William Cao, founder and chief executive officer of Gracell Biotechnologies, discusses the Shanghai-based company's initial public offering in the U.S. and its growth strategy. Gracell is developing treatments for various cancers. Cao speaks with Shery Ahn and Haidi Stroud-Watts on "Bloomberg Daybreak: Asia." (Source: Bloomberg)
